ESAB Q3 beats: core adj. EPS $0.92, raises FY core adj. EPS guidance to $4.00-$4.10

ESAB Corp

2022-Q3 EPS reported $2.69 revenue$1,929,353,000

GAAP EPS $0.88, core adjusted diluted EPS $0.92; net income $53M from continuing ops.
Revenue $620M (+2% reported); core organic growth 10% excluding Russia and currency.
Core adjusted EBITDA $96M, up 5% YoY; reaffirms 2022 core organic growth 11-14%.
Raises FY core adjusted EPS guidance to $4.00-$4.10 from $3.85-$4.05; core EBITDA narrowed to $405-415M.
Completed Ohio Medical acquisition; gas control platform now >$400M sales with >40% gross margins.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ESAB Corp reported third quarter of 2022 results: revenue $620 million, net income $53 million, EPS $0.88 diluted per share. Guidance reaffirmed.

Period: third quarter of 2022
Revenue: $620 million
Net income: $53 million
EPS: $0.88 diluted per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

The Company reported third quarter sales of $620 million, an increase of 2% on a reported basis, and core (excluding Russia) sales of $577 million, or 10% higher core organic growth before currency translation impacts. ESAB also reported third quarter GAAP net income from continuing operations attributable to ESAB of $53 million , $0.88 diluted per share

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

ESAB Corp filing history →

Source: SEC EDGAR

accession 0001877322-22-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.